Cargando…

Prevention of Diabetes and Cardiovascular Disease in Obesity

Obesity is one of the major risk factors for the development of both impaired glucose tolerance (IGT, or prediabetes) and type 2 diabetes (T2D), and its prevalence worldwide drives toward an increased rate of cardiovascular morbidity and mortality. Given the estimations of the World Health Organizat...

Descripción completa

Detalles Bibliográficos
Autores principales:	La Sala, Lucia, Pontiroli, Antonio E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663329/ https://www.ncbi.nlm.nih.gov/pubmed/33142938 http://dx.doi.org/10.3390/ijms21218178

Ejemplares similares

Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk
por: La Sala, Lucia, et al.
Publicado: (2020)

Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Sala, Lucia La, et al.
Publicado: (2021)

Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity – diabetes?
por: Pontiroli, Antonio E., et al.
Publicado: (2020)

New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
por: La Sala, Lucia, et al.
Publicado: (2021)

High plasma renin activity associates with obesity-related diabetes and arterial hypertension, and predicts persistent hypertension after bariatric surgery
por: La Sala, Lucia, et al.
Publicado: (2021)

Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective
por: La Sala, Lucia, et al.
Publicado: (2020)

Correction: La Sala et al. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int. J. Mol. Sci. 2021, 22, 10643
por: La Sala, Lucia, et al.
Publicado: (2023)

Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study
por: Pontiroli, Antonio E., et al.
Publicado: (2016)

Obesity management for cardiovascular disease prevention
por: Hritani, Rama, et al.
Publicado: (2023)

Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
por: Yang, Chung Shu, et al.
Publicado: (2017)

Clock Genes, Inflammation and the Immune System—Implications for Diabetes, Obesity and Neurodegenerative Diseases
por: Vieira, Elaine, et al.
Publicado: (2020)

The epigenetics of diabetes, obesity, overweight and cardiovascular disease
por: Smail, Harem Othman
Publicado: (2019)

The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications
por: Testa, Roberto, et al.
Publicado: (2017)

Effects of Weight Loss in Metabolically Healthy Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet
por: Sesti, Giorgio, et al.
Publicado: (2011)

Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters
por: Pontiroli, Antonio E, et al.
Publicado: (2009)

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
por: González, N., et al.
Publicado: (2017)

Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
por: Pontiroli, Antonio E., et al.
Publicado: (2019)

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
por: Bardini, Gianluca, et al.
Publicado: (2010)

Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention
por: Perone, Francesco, et al.
Publicado: (2023)

Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
por: Saha, Sanjib, et al.
Publicado: (2010)

The Role of Zinc Homeostasis in the Prevention of Diabetes Mellitus and Cardiovascular Diseases
por: Tamura, Yukinori
Publicado: (2021)

Baseline conditions and nutritional state upon hospitalization are the greatest risks for mortality for cardiovascular diseases and for several classes of diseases: a retrospective study
por: Loreggian, Lara, et al.
Publicado: (2022)

Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease
por: Cojocaru, Karina-Alexandra, et al.
Publicado: (2023)

Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008)

Editorial: Cardiovascular Diseases Related to Diabetes and Obesity
por: Rajesh, Mohanraj, et al.
Publicado: (2022)

Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases
por: Shi, Yuguang
Publicado: (2010)

Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease
por: Cuomo, Paola, et al.
Publicado: (2022)

The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil
por: Ditano-Vázquez, Paola, et al.
Publicado: (2019)

Cardiovascular Risk Factors in Children with Obesity, Preventive Diagnostics and Possible Interventions
por: Močnik, Mirjam, et al.
Publicado: (2021)

Type 1 diabetes and cardiovascular disease
por: Schnell, Oliver, et al.
Publicado: (2013)

Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models
por: Balram, Amrita, et al.
Publicado: (2022)

Lycopene in the Prevention of Cardiovascular Diseases
por: Przybylska, Sylwia, et al.
Publicado: (2022)

The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes
por: Blankstein, Ron, et al.
Publicado: (2017)

Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
por: Leuci, Rosalba, et al.
Publicado: (2020)

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer
por: Janssen, Joseph A. M. J. L.
Publicado: (2021)

Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease
por: Kereliuk, Stephanie M., et al.
Publicado: (2022)

Tea Plant (Camellia sinensis): A Current Update on Use in Diabetes, Obesity, and Cardiovascular Disease
por: Brimson, James Michael, et al.
Publicado: (2022)

Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Pontiroli, Antonio E., et al.
Publicado: (2023)

Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases
por: Hijová, Emília
Publicado: (2022)

T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
por: Shirakawa, Kohsuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vr372qacrhnvoc0oh4q9c35pc0